7 Stocks Under $10 to Trade for Big Profits

As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Stocks that are in favor and making large moves is a segment of the market that I tweet about on a regular basis.These are also the exact type of stocks that I love to trade and alert to my subscribers in real-time.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Bio Blast Pharma

  • Thursday's Range: $1.89-$2.10
  • 52-Week Range: $1.65-$8.50
  • Thursday's Volume: 297,000
  • Three-Month Average Volume: 399,289

Bio Blast Pharma  (ORPN) , a clinical development-stage biopharmaceutical company, focuses on the identification, licensing, acquisition, development and commercialization clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. This stock closed up 9.5% to $2.07 in Thursday's trading session.

From a technical perspective, Bio Blast Pharma spiked sharply higher on Thursday back above its 20-day moving average of $1.95 a share with lighter-than-average volume. This jump to the upside is now quickly pushing shares of Bio Blast Pharma within range of triggering a near-term breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $2.10 to $2.14 a share and then above its 50-day moving average of $2.28 a share with high volume.

Traders should now look for long-biased trades in Bio Blast Pharma as long as it's trending above Thursday's intraday low of $1.89 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 399,289 shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $2.45 to $2.60, or even $3 to $3.13 a share.

Heat Biologics

  • Thursday's Range: $0.60-$0.64
  • 52-Week Range: $0.40-$7.59
  • Thursday's Volume: 286,000
  • Three-Month Average Volume: 657,762

Heat Biologics  (HTBX) , a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the U.S. This stock traded up 5.8% to 63 cents per share in Thursday's trading session.

From a technical perspective, Heat Biologics spiked sharply higher on Thursday right above its 20-day moving average of 57 cents per share with lighter-than-average volume. This stock has been uptrending a bit over the last few weeks, with shares moving higher off its new 52-week low of 40 cents per share to its intraday high on Thursday of 64 cents per share. During that uptrend, shares of Heat Biologics have been consistently making higher lows and higher highs, which is bullish technical price action. This move is now quickly pushing this stock within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at 64 cents to its 50-day moving average of 66 cents per share with high volume.

Traders should now look for long-biased trades in Heat Biologics as long as it's trending above its 20-day moving average of 57 cents per share or above more near-term support at 50 cents per share and then once it sustains a move or close above those breakout levels with volume that hits near or above 657,762 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at 70 to 74 cents, or even 78 to 90 cents per share.

Avid Technology

  • Thursday's Range: $5.80-$5.95
  • 52-Week Range: $5.26-$18.10
  • Thursday's Volume: 1.22 million
  • Three-Month Average Volume: 360,075

Avid Technology  (AVID)  develops, markets, sells and supports software and hardware for digital media content production, management and distribution worldwide. This stock traded up 1.7% to $5.90 in Thursday's trading session.

From a technical perspective, Avid Technology spiked modestly higher on Thursday right above its 20-day moving average of $5.66 a share with monster upside volume flows. This stock has been uptrending a bit over the last few weeks, with shares moving higher off its new 52-week low of $5.26 a share to its recent high of $6.05 a share. During that uptrend, this stock has been making mostly higher lows and higher highs, which is bullish technical price action. This high-volume rip on Thursday is now quickly pushing shares of Avid Technology within range of triggering a big breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to clear its 50-day moving average of $6 a share to some more key resistance levels at $6.05 to around $6.20 a share with high volume.

Traders should now look for long-biased trades in Avid Technology as long as it's trending above its 20-day moving average of $5.66 a share or above more support around $5.50 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 360,075 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $6.80 to $7, or even its 200-day moving average of $7.17 to around $7.50 a share.

Aegerion Pharmaceuticals

  • Thursday's Range: $1.57-$1.74
  • 52-Week Range: $1.57-$20.45
  • Thursday's Volume: 700,000
  • Three-Month Average Volume: 809,841

Aegerion Pharmaceuticals  (AEGR) , a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the U.S. This stock traded up 7.4% to $1.73 in Thursday's trading session.

From a technical perspective, Aegerion Pharmaceuticals ripped sharply higher on Thursday off its new 52-week low of $1.57 a share with lighter-than-average volume. This stock has been downtrending badly over the last six months, with shares collapsing from over $10 a share to its new 52-week low of $1.57 a share. During that downtrend, this stock has been consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of Aegerion Pharmaceuticals spiked off that $1.57 low Thursday, and the stock is now quickly trending within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $1.80 to $1.83 a share with high volume.

Traders should now look for long-biased trades in Aegerion Pharmaceuticals as long as it's trending above its new 52-week low of $1.57 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 809,841 shares. If that breakout takes hold soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $2 to its 20-day moving average of $2.10, or even $2.36 to $2.50 a share.

Calumet Specialty Products Partners

  • Thursday's Range: $3.53-$3.95
  • 52-Week Range: $3.42-$28.33
  • Thursday's Volume: 1.20 million
  • Three-Month Average Volume: 1.01 million

Calumet Specialty Products Partners  (CLMT)  produces and sells specialty hydrocarbon products in North America. This stock traded up 9% to $3.86 in Thursday's trading session.

From a technical perspective, Calumet Specialty Products Partners ripped sharply higher on Thursday right off its new 52-week low of $3.42 a share and back above its 20-day moving average of $3.84 a share with above-average volume. This high-volume rip to the upside is now quickly pushing shares of Calumet Specialty Products Partners within range of triggering a big breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $3.95 to $4.07 a share with high volume.

Traders should now look for long-biased trades in Calumet Specialty Products Partners as long as it's trending above Thursday's intraday low of $3.53 a share or above its new 52-week low of $3.42 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.01 million shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out is next major overhead resistance levels at $4.44 to $5, or even $5.14 to $5.50 a share.

Walter Investment Management

  • Thursday's Range: $4.57-$5.86
  • 52-Week Range: $4.17-$23.70
  • Thursday's Volume: 136,000
  • Three-Month Average Volume: 306,835

Walter Investment Management  (WAC) , a diversified mortgage banking firm, focuses primarily on the servicing and origination of residential loans in the U.S. This stock traded up 4.1% to $4.81 in Thursday's trading session.

From a technical perspective, Walter Investment Management spiked notably higher on Thursday right into its 20-day moving average of $4.82 a share with lighter-than-average volume. This stock recently formed a double bottom chart pattern, after shares found some buying interest at $4.20 to $4.17 a share. Following that potential bottom, shares of Walter Investment Management have now started to rip higher and quickly move within range of triggering a big breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out Thursday's intraday high of $4.86 a share to some more key resistance at $4.91 a share with high volume.

Traders should now look for long-biased trades in Walter Investment Management as long as it's trending above those recent double bottom support levels and then once it sustains a move or close above those breakout levels with volume that hits near or above 306,835 shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $5.25 to just over $6 a share.

Amyris

  • Thursday's Range: $0.53-$0.58
  • 52-Week Range: $0.49-$2.62
  • Thursday's Volume: 701,000
  • Three-Month Average Volume: 520,238

Amyris  (AMRS)  provides various alternatives to a range of petroleum-sourced products worldwide. This stock traded up 10.4% to 56 cents per share in Thursday's trading session.

From a technical perspective, Amyris ripped sharply higher on Thursday right above its new 52-week low of 49 cents per share with strong upside volume flows. This reversal pattern with volume off its recent lows is now quickly pushing shares of Amyris within range of triggering a big breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out Thursday's intraday high of 58 cents per share and then above more key resistance levels at 60 to 61 cents per share with high volume.

Traders should now look for long-biased trades in Amyris as long as it's trending above Thursday's intraday low of 53 cents per share or above its new 52-week low of 49 cents per share and then once it sustains a move or close above those breakout levels with volume that registers near or above 520,238 shares. If that breakout kicks off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at 65 to 70 cents, or even 80 to 90 cents per share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.

More from Opinion

The Good, the Bad, and the Unknowns of AI and Apple Watches

The Good, the Bad, and the Unknowns of AI and Apple Watches

Flashback Friday: Bye Bye FAANG

Flashback Friday: Bye Bye FAANG

Micron Slumps After Issuing Light Guidance: 7 Key Takeaways

Micron Slumps After Issuing Light Guidance: 7 Key Takeaways

Throwback Thursday: Let's Talk Tilray

Throwback Thursday: Let's Talk Tilray

Amazon's Reported Plans to Greatly Expand Its Cashier-Free Stores: 5 Takeaways

Amazon's Reported Plans to Greatly Expand Its Cashier-Free Stores: 5 Takeaways